New Delhi: Scientists are constantly doing research for the treatment and prevention of coronavirus. A large study in London has shown that giving aspirin to a critically ill corona patient does not reduce the risk of contracting the disease. In a research last year regarding the treatment of corona patients, it was revealed that the risk of death in corona patients taking aspirin is reduced.
Commonly available in any drug store, this medicine is used to relieve minor stiffness, pain and fever caused by headaches, female periods, muscle injuries, cold and flu, and arthritis. People also use it to reduce the risk of heart attack and stroke or to thin the blood in heart disease, as did the patients in this study.
New research in London on aspirin drug:
A new research being conducted in London on the aspirin drug says that it has not shown any signs of reducing the risk of death. Earlier, researchers from Oxford University had hoped that aspirin effective in preventing blood clotting would prove effective in corona patients. Blood clots form in serious patients of corona, due to which thousands of patients die. In the study, scientists felt that the cheap drug aspirin would be very effective. After this research, aspirin was also given to serious patients, but now new research has not revealed any benefits of its benefits.
No evidence of survival of severe corona patients taking aspirin:
Professor Peter Harvey, an infectious disease specialist at Oxford University, claimed that there are very few reports of patients seriously suffering from corona who came alive from the hospital after using this medicine. Professor Harvey said that there is no evidence that serious patients taking aspirin did not need ventilators. Based on this evidence, it does not appear that aspirin has been of great benefit to COVID patients.